ArticleFrontiers in pharmacology2023

A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database.

Fan Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.